IRIS
MESSINA, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.358
EU - Europa 2.074
AS - Asia 1.760
SA - Sud America 390
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 31
OC - Oceania 4
Totale 6.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.217
RU - Federazione Russa 1.114
SG - Singapore 601
CN - Cina 568
IT - Italia 490
BR - Brasile 313
HK - Hong Kong 196
VN - Vietnam 161
SE - Svezia 139
BD - Bangladesh 88
FR - Francia 73
CA - Canada 60
DE - Germania 60
GB - Regno Unito 51
MX - Messico 35
AR - Argentina 32
IN - India 29
FI - Finlandia 21
IE - Irlanda 20
PL - Polonia 18
ES - Italia 15
EC - Ecuador 13
ID - Indonesia 13
JP - Giappone 12
NL - Olanda 12
TR - Turchia 12
CR - Costa Rica 10
CO - Colombia 9
IQ - Iraq 9
ZA - Sudafrica 9
AT - Austria 8
JM - Giamaica 8
JO - Giordania 8
RS - Serbia 8
UA - Ucraina 8
LT - Lituania 7
MY - Malesia 7
CL - Cile 6
PH - Filippine 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
HN - Honduras 5
PK - Pakistan 5
RO - Romania 5
TW - Taiwan 5
VE - Venezuela 5
AU - Australia 4
GR - Grecia 4
KR - Corea 4
NI - Nicaragua 4
PE - Perù 4
SV - El Salvador 4
UY - Uruguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
KE - Kenya 3
KZ - Kazakistan 3
LC - Santa Lucia 3
MA - Marocco 3
NO - Norvegia 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
ZW - Zimbabwe 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
IL - Israele 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
AI - Anguilla 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
MK - Macedonia 1
MW - Malawi 1
PR - Porto Rico 1
Totale 6.617
Salva come PNG Salva come JPEG
Città #
Dallas 405
Singapore 311
Ashburn 303
Moscow 212
San Jose 204
Hong Kong 192
Milan 124
Council Bluffs 117
Shanghai 94
New York 77
Hefei 72
Rome 60
Ho Chi Minh City 57
Lauterbourg 56
Beijing 52
Los Angeles 52
Phoenix 47
Santa Clara 45
Princeton 41
São Paulo 41
Lawrence 39
Munich 25
Hanoi 23
Boardman 21
Denver 21
Orem 21
Naples 19
Dublin 18
Miano 18
Montreal 18
Turin 18
Warsaw 17
Atlanta 16
Florence 15
Guangzhou 14
Buffalo 12
Chennai 12
Nuremberg 12
Stockholm 12
Seattle 11
Biên Hòa 10
Chicago 10
Curitiba 10
Houston 10
Helsinki 9
Manchester 9
Mexico City 9
Tokyo 9
Washington 9
Amman 8
Belgrade 8
Brooklyn 8
Genoa 8
Philadelphia 8
Poplar 8
Tianjin 8
Ankara 7
Bologna 7
Brasília 7
Cincinnati 7
Haiphong 7
Hải Dương 7
London 7
Newark 7
San José 7
St Louis 7
Turku 7
Charlotte 6
Da Nang 6
Johannesburg 6
Miami 6
Omaha 6
Perugia 6
Querétaro 6
Ribeirão das Neves 6
Belo Horizonte 5
Bergamo 5
Betim 5
Bogotá 5
Hangzhou 5
Lappeenranta 5
Padua 5
Palermo 5
Porto Alegre 5
Quito 5
Recife 5
Rho 5
Rio de Janeiro 5
Shenzhen 5
Toronto 5
Amsterdam 4
Baghdad 4
Baguio City 4
Boston 4
Calgary 4
Columbus 4
Falkenstein 4
Guayaquil 4
Kingston 4
Kuala Lumpur 4
Totale 3.305
Salva come PNG Salva come JPEG
Nome #
A novel scoring approach to identify responders to erenumab in clinical practice 191
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 183
Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study 182
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 182
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 179
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 173
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 164
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 134
Imaging the brain and vascular reactions to headache treatments: a systematic review 128
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 127
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 126
Imaging of Migraine and Vestibular Migraine 122
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study 112
Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy 109
Tension-type headache 108
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 107
Biomarkers of Migraine and Cluster Headache: Differences and Similarities 106
An update on migraine: current understanding and future directions 106
Clinical correlates of hypothalamic functional changes in migraine patients 102
CGRP – a target for acute therapy in migraine: Clinical data 98
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 95
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 94
Functional MRI in migraine 93
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report 93
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 93
Candesartan in migraine prevention: results from a retrospective real-world study 93
Stress in paediatric migraine: a trigger factor? 92
DIFFERENCES IN BRAIN STRUCTURE AND FUNCTION IN PRIMARY HEADACHE DISORDERS: A MULTIMODAL MRI STUDY 91
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 87
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 87
Tracking the evolution of non-headache symptoms through the migraine attack 85
Cortical abnormalities in patients with migraine: a surface-based analysis. 85
Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial 82
Insights into migraine attacks from neuroimaging 80
Brain structural and functional abnormalities in Fahr's disease: a report of two cases 79
Dysregulation of multisensory processing stands out from an early stage of migraine: a study in pediatric patients 79
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 77
Neural correlates of visuospatial processing in migraine: does the pain network help? 76
A novel scoring approach to identify responders to erenumab in clinical practice 72
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 71
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 71
A review of recent literature on functional MRI and personal experience in two cases of definite vestibular migraine 70
What imaging has revealed about migraine and chronic migraine 67
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. 67
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patients 66
Structural brain abnormalities in patients with vestibular migraine 65
Unveiling Functional and Structural Brain MRI Alterations in Opioid Use Disorder 64
Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. 62
The Chronic Migraine Brain: What Have We Learned From Neuroimaging? 62
Pathophysiological Bases of Comorbidity in Migraine 62
Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations 61
Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 61
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State? 61
Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 61
Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A? 60
What We Gain From Machine Learning Studies in Headache Patients 59
Super- and absolute responders to anti-cgrp monoclonal antibodies in migraine: A one-year multicenter, prospective, observational study 56
Multiple sclerosis imaging: recent advances. 56
Recent advances in headache neuroimaging 56
Biomarkers of treatment response 54
White matter microstructure abnormalities in pediatric migraine patients 51
Editorial: Still Searching for the Origin of Migraine: From Comorbidities to Chronicization 49
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society 48
Imaging the migrainous brain: the present and the future 48
fMRI of the sensorimotor system 46
Resting-state fMRI functional connectivity: a new perspective to evaluate pain modulation in migraine? 46
MRI studies can predict progression of disease years before it occurs 45
Structural brain MRI abnormalities in pediatric patients with migraine 45
Imaging of migraine and vestibular migraine 45
Estimating brain lesion volume change in multiple sclerosis by subtraction of magnetic resonance images 44
Exploring the role of the pons and hypothalamus in migraine disease progression 42
Insights into Migraine Treatments. Towards Personalized Medicine 42
fMRI of pain 42
Migraine treatments: what have we learned from neuroimaging? 42
Resting State Functional Connectivity Changes of the Hypothalamus in Migraine Patients: A Cross-Sectional and Longitudinal Study 41
Resting State Functional Connectivity Changes of the Hypothalamus in Migraine Patients: A Cross-Sectional and Longitudinal Study 39
Neural correlates of visuospatial processing in migraine patients: does the pain network interfere? 39
Neural Correlates of Visuospatial Processing in Migraine Patients: Does the Pain Network Interfere? 38
Neural correlates of visuospatial processing in migraine patients: does the pain network interfere? 36
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis 35
Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association 35
RESTING STATE FUNCTIONAL CONNECTIVITY CHANGES OF THE HYPOTHALAMUS IN MIGRAINE PATIENTS: A CROSS-SECTIONAL AND LONGITUDINAL STUDY 34
Unveiling Resting-State Functional Connectivity Patterns in Patients With Migraine: A REFORM Study 25
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 1 24
An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference 21
Exploring the role of the pons and hypothalamus in migraine progression 18
null 17
Exploring the role of the pons and hypothalamus in migraine progression 17
Combining treatments for migraine prophylaxis: the state-of-the-art 16
Correction: Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study (Neurology and Therapy, (2026), 10.1007/s40120-026-00971-7) 15
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials 14
Health equity, care access and quality in headache – part 2 14
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study 5
Totale 6.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 11 0 4 5 2 1 1 6 2
2022/2023255 88 50 26 1 7 29 15 18 7 1 7 6
2023/2024258 6 11 31 22 41 36 8 32 7 9 16 39
2024/2025925 95 23 28 23 44 85 77 91 141 154 71 93
2025/20264.007 258 312 419 511 270 147 283 274 1.035 186 166 146
2026/20271.288 220 289 299 480 0 0 0 0 0 0 0 0
Totale 6.802